Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Koh

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
Alimentary Pharmacology & Therapeutics|May 28, 2021
Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapyJulian Hercun, Grace E Kim, Ben L Da, et al.
Hepatology (Baltimore, Md.)|April 20, 2017
Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entityChristopher Koh, Sasan Sakiani, Pallavi Surana, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2025
Clinical and Genetic Associations in Cephalosporin-Induced Liver Injury: Insights From the Drug-Induced Liver Injury NetworkRaj Vuppalanchi, Yi-Ju Li, Don C Rockey, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2025
Editorial: Cephalosporin-Induced Liver Injury-Interesting but Tricky. Authors' ReplyRaj Vuppalanchi, Jay H Hoofnagle, Don C Rockey, et al.
Viruses|March 17, 2019
Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) InfectionMasataka Tsuge, Takuro Uchida, Kevin Walsh, et al.
World Journal of Gastroenterology|January 18, 2013
Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two casesAna Paula Oppenheimer, Christopher Koh, Mary McLaughlin, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 studyCihan Yurdaydin, Onur Keskin, Çağdaş Kalkan, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
Antiviral Research|May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 yearsPallavi Surana, Devika Kapuria, Carly Broadwell, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Alimentary Pharmacology & Therapeutics|May 28, 2021
Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapyJulian Hercun, Grace E Kim, Ben L Da, et al.
Hepatology (Baltimore, Md.)|April 20, 2017
Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entityChristopher Koh, Sasan Sakiani, Pallavi Surana, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2025
Clinical and Genetic Associations in Cephalosporin-Induced Liver Injury: Insights From the Drug-Induced Liver Injury NetworkRaj Vuppalanchi, Yi-Ju Li, Don C Rockey, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2025
Editorial: Cephalosporin-Induced Liver Injury-Interesting but Tricky. Authors' ReplyRaj Vuppalanchi, Jay H Hoofnagle, Don C Rockey, et al.
Viruses|March 17, 2019
Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) InfectionMasataka Tsuge, Takuro Uchida, Kevin Walsh, et al.
World Journal of Gastroenterology|January 18, 2013
Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two casesAna Paula Oppenheimer, Christopher Koh, Mary McLaughlin, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 studyCihan Yurdaydin, Onur Keskin, Çağdaş Kalkan, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
Antiviral Research|May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 yearsPallavi Surana, Devika Kapuria, Carly Broadwell, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Pageof 16